Johnson & Johnson JNJ
271.22
0.54
0.20%
as of 25 Sep
- Market cap
- $652.8B
- P/E
- 31.4×
Follow JNJ
S&P 500 Member
Dividend Aristocrat
Cash Flow Champion (3y)
Revenue Champion (3y)
Insider Buys (last 12m)
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 25.74% | 26.42% | 35.03% | 33.62% |
+8 more TTM periods Free account |
|
| 10.67% | 10.66% | 14.13% | 13.54% | ||
ROIC |
15.51% | 16.13% | 20.19% | 19.66% | |
Return on Tangible Assets |
73.92% | 85.09% | 108.66% | 96.32% | |
Average Days of Receivables |
70.99 | 67.12 | 66.57 | 69.76 | |
Free Cash Flow per Share |
9.44 | 7.58 | 8.48 | 8.33 | |
Free Cash Flow |
22,724.00 | 18,254.00 | 20,418.00 | 20,057.00 | |
Capital Expenditures |
(4,884.00) | (4,616.00) | (4,112.00) | (4,147.00) | |
Piotroski F-Score |
6.00 | 4.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
19.30% | 16.25% | 17.39% | 17.64% | |
Accounts Receivable Turnover |
5.31 | 5.71 | 5.88 | 5.46 | |
Accounts Payable Turnover |
3.36 | 3.10 | 2.71 | 3.17 | |
Inventory Turnover |
2.20 | 2.28 | 2.27 | 2.20 | |
Average Days of Payables |
107.11 | 123.14 | 144.66 | 119.43 | |
Days of Inventory on Hand |
175.88 | 171.68 | 171.20 | 175.53 | |
Tax Rate |
(0.17) | (0.16) | (0.18) | (0.20) | |
Research and Development Expense of Revenue |
15.42% | 15.53% | 15.57% | 17.05% | |
Selling, General and Administrative Expense of Revenue |
25.67% | 25.53% | 25.14% | 25.37% | |
Share Based Compensation of Revenue |
1.44% | 1.42% | 1.44% | 1.39% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.31 | 1.09 | 0.92 | 0.96 | |
Depreciation/Fixed assets |
0.33 | 0.33 | 0.32 | 0.33 | |
Capex/Depreciation |
(0.63) | (0.60) | (0.55) | (0.56) | |
Revenue per Share |
40.68 | 40.01 | 39.13 | 38.26 | |
Operating CF per Share |
11.47 | 9.49 | 10.19 | 10.05 | |
Capex per Share |
(2.03) | (1.92) | (1.71) | (1.72) | |
Capex to Sales |
0.05 | 0.05 | 0.04 | 0.05 | |
Net Profit Margin |
21.48% | 21.83% | 28.46% | 27.26% |
Columns are period end dates